Solid Organ Transplant Complications clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Tabelecleucel in Participants with Epstein-barr Virus-associated Diseases
open to all eligible people
The purpose of this study is to assess the efficacy and safety of tabelecleucel in participants with Epstein-Barr virus (EBV) associated diseases.
at UC Davis UCLA
Our lead scientists for Solid Organ Transplant Complications research studies include Herbert Eradat.
Last updated: